Phillip T Ordoukhanian

Title: The Innovations of Phillip T Ordoukhanian

Introduction

Phillip T Ordoukhanian is a notable inventor based in La Jolla, California. He has made significant contributions to the field of genomics, particularly in the area of kidney transplant rejection. With a total of 6 patents, his work has advanced the understanding of gene expression profiles and their implications in medical diagnostics.

Latest Patents

One of his latest patents focuses on gene expression profiles associated with sub-clinical kidney transplant rejection. Through a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, he and his team have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These gene sets are instrumental for diagnosis, prognosis, and monitoring of subAR. Another significant patent involves methods of sample preparation, which provides methods, compositions, and kits that enhance nucleic acid analysis techniques. These innovations allow for more reliable and accurate targeted, multiplexed, high-throughput sequencing, and can be utilized for sequencing target loci of nucleic acid.

Career Highlights

Phillip has worked with esteemed organizations such as The Scripps Research Institute and Jumpcode Genomics, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

He has collaborated with notable colleagues, including Daniel R Salomon and Steven Robert Head. Their combined expertise has furthered the impact of their research in genomics and medical diagnostics.

Conclusion

Phillip T Ordoukhanian's contributions to the field of genomics through his innovative patents and collaborations have significantly advanced medical diagnostics. His work continues to influence the understanding of kidney transplant rejection and improve patient outcomes.